← Leaderboards
Sydney Lamerand
University Of Pittsburgh At Pittsburgh
$143,420
Attributed
$143,420
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49K · FY2022–24$50K$37.5K$25K$12.5K$0
'22
'23
'24
Funding mix
By agency
NIH$143,420 · 1
By mechanism
F31$143,420 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Bradley K Taylor$17,950,936
- Yan Xu$24,756,156
- Nam V Vo$9,841,127
- Sean P Farris$4,481,772
- Zongqi Xia$6,092,494
Others in their field
Other Rising Stars on “Fda Approved”
- Suma Babu · Massachusetts General Hospital$26,348,733
- Sabrina Paganoni · Massachusetts General Hospital$26,348,733
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Michael George Natchus · Emory University$10,548,554
- John Alam · Eip Pharma, Inc.$10,411,018
- George Gaitanaris · Omeros Corporation$6,689,019
Research focus
Fda ApprovedFunctional DisorderExperimental StudyAgonistAllodyniaExperimental DesignsAnalgesicsAffectBindingAntagonistAttenuatedChronic PainCns Autoimmune DiseaseBehaviorBehavioralComorbidityBehavioral PharmacologyCouplingCytokineData AnalysesDemyelinationsDesignExperimental Autoimmune EncephalomyelitisFuture
Grant awards (3)
Microglia and S1PR1 Signaling in Multiple Sclerosis Associated Neuropathic Pain$48,974
F31 · FY2024 · NS · contact PI
Microglia and S1PR1 Signaling in Multiple Sclerosis Associated Neuropathic Pain$47,694
F31 · FY2023 · NS · contact PI
Microglia and S1PR1 Signaling in Multiple Sclerosis Associated Neuropathic Pain$46,752
F31 · FY2022 · NS · contact PI